VIDEO DOI: https://doi.org/10.48448/4rdf-9v24
July 11, 2022
Atlanta, United States
Efficacy and Safety of Tirzepatide Versus Semaglutide in a Hispanic or Latino Population: A Prespecified Subgroup Analysis of SURPASS-2
Next from ENDO 2022
Widening Economic Disparity in Rates of Readmissions Following Hospitalizations for Hyperglycemic Emergencies Among US Adults over a Decade.
11 July 2022